• Ecolab reported its third quarter 2025 results in the past week, posting US$4.17 billion in revenue, an increase from the previous year, but net income and earnings per share declined compared to the same quarter last year.
• The company's ongoing buyback program continued, with 600,000 shares repurchased in the third quarter, bringing total buybacks under its 2010 plan to over 57.55 million shares, or more than 21% of shares outstanding.
• We'll examine how Ecolab's higher revenue but lower net income in the past quarter reshapes its longer-term investment narrative.

AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Ecolab Investment Narrative Recap

Investors who own Ecolab typically believe in the power of its recurring revenue base, market share gains, and ability to offset cost pressures through pricing and innovation. The most recent quarterly results, higher revenue but reduced net income, do not appear to materially shift the near-term catalyst of value pricing adoption through its One Ecolab initiative, but they reinforce the risk of margin compression from rising raw material costs and ongoing trade-related headwinds.

Among the recent announcements, the update on Ecolab’s share buyback program stands out, with 600,000 shares repurchased in the third quarter. While ongoing buybacks can support shareholder value, their ability to offset earnings pressure from input cost inflation and softer industrial demand will be closely monitored over the coming quarters.

However, investors should also be aware that if raw material tariffs intensify, the pressure on Ecolab’s margins could become even more pronounced...

Ecolab's outlook projects $18.4 billion in revenue and $2.8 billion in earnings by 2028. This is based on a 5.4% annual revenue growth rate and an earnings increase of $0.7 billion from the current $2.1 billion.

Uncover how Ecolab's forecasts yield a $286.10 fair value, a 7% upside to its current price.

Exploring Other Perspectives

Four fair value estimates from the Simply Wall St Community place Ecolab’s worth between US$232.57 and US$286.10 per share. Such variation highlights how opinions can diverge, especially given that profit margins remain vulnerable to global tariffs and input costs.

Explore 4 other fair value estimates on Ecolab - why the stock might be worth 13% less than the current price!

Build Your Own Ecolab Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Ecolab research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Ecolab research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ecolab's overall financial health at a glance.

Looking For Alternative Opportunities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• These 14 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.
• Uncover the next big thing with financially sound penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.